Livotech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Livotech General Information

Description

Developer of drugs intended to provide treatment for various diseases. The company develops drugs that can treat different diseases using messenger ribonucleic acid targets, enabling doctors to treat genetic diseases by giving patients the correct version of a defective gene.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 193 Munji-ro, Room T330, Jinri Hall
  • Yuseong-gu, Munji-dong, Kais Munji Campus
  • Daejeon
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 193 Munji-ro, Room T330, Jinri Hall
  • Yuseong-gu, Munji-dong, Kais Munji Campus
  • Daejeon
  • South Korea

Livotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Livotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 31-Jul-2025 Completed Startup
3. Later Stage VC 03-Feb-2025 Completed Startup
2. Seed Round 15-Jan-2021 Completed Startup
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view Livotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Livotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Livotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
TBIC KAIST Accelerator/Incubator
DAYLI Partners Venture Capital Minority
Union Investment Partners Venture Capital Minority
KU Startup Accelerator/Incubator
To view Livotech’s complete investors history, request access »

Ready to get started?

Request a free trial

Livotech FAQs

  • When was Livotech founded?

    Livotech was founded in 2020.

  • Where is Livotech headquartered?

    Livotech is headquartered in Daejeon, South Korea.

  • What is the size of Livotech?

    Livotech has 10 total employees.

  • What industry is Livotech in?

    Livotech’s primary industry is Drug Discovery.

  • Is Livotech a private or public company?

    Livotech is a Private company.

  • What is Livotech’s current revenue?

    The current revenue for Livotech is .

  • How much funding has Livotech raised over time?

    Livotech has raised $1.72M.

  • Who are Livotech’s investors?

    TBIC KAIST, DAYLI Partners, Union Investment Partners, and KU Startup have invested in Livotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process